Viridian Therapeutics, Inc.\DE (VRDN) Shares Issued (2014 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Shares Issued of $67695.0 for Q4 2016, up 60.78% year-over-year from $42104.0 in Q1 2016, and down 88.35% quarter-over-quarter from $580941.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Shares Issued (2014 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Shares Issued history runs 3 years deep, the most recent figure standing at $67695.0 for Q4 2016.
- In Q4 2016, Shares Issued rose 60.78% year-over-year to $67695.0; the TTM figure through Dec 2016 stood at $67695.0 (up 60.78% YoY), while the FY2016 annual figure was $67695.0, up 60.78% from the prior year.
- Shares Issued for Q4 2016 stood at $67695.0, down from $580941.0 in the prior quarter.
- The five-year high for Shares Issued was $673027.0 in Q3 2015, with the low at $42104.0 in Q4 2015.
- The 3-year median for Shares Issued is $179000.0 (2015), against an average of $341382.6.
- The sharpest annual moves came in 2015 and 2016: Shares Issued plunged 72.3% in 2015, then surged 247.95% in 2016.
- Viridian Therapeutics, Inc.\DE's Shares Issued stood at $152000.0 in 2014, then slumped by 72.3% to $42104.0 in 2015, then soared by 60.78% to $67695.0 in 2016.
- Business Quant data shows VRDN's Shares Issued at $67695.0 in Q4 2016, $580941.0 in Q3 2016, and $622837.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 67,695.00 |
| Dec 31, 2016 | 67,695.00 |
| Sep 30, 2016 | 580,941.00 |
| Sep 30, 2016 | 580,941.00 |
| Jun 30, 2016 | 622,837.00 |
| Jun 30, 2016 | 622,837.00 |
| Mar 31, 2016 | 580,960.00 |
| Mar 31, 2016 | 580,960.00 |
| Dec 31, 2015 | 42,104.00 |
| Dec 31, 2015 | 42,104.00 |
| Sep 30, 2015 | 673,027.00 |
| Sep 30, 2015 | 673,027.00 |
| Jun 30, 2015 | 179,000.00 |
| Jun 30, 2015 | 179,000.00 |
| Mar 31, 2015 | 173,879.00 |
| Mar 31, 2015 | 173,879.00 |
| Dec 31, 2014 | 152,000.00 |
| Dec 31, 2014 | 152,000.00 |